A drug designed to combat Tuberous Sclerosis is being trialled at Cardiff University and could also be used to treat autism. Everolimus has already proven effective when used to treat kidney growths and grain tumours - reducing their size in many cases.
Tuberous Sclerosis is a genetic disorder characterised by the development of tumours in many organs, including the skin and kidneys. It can also affect the brain, leading to epilepsy and often ADHD and autism.
For more health stories click here.
More top news
North Wales Police have referred themselves to the IPCC after one of their officers fired a taser at a man.
A British High Court judge has been asked to come to the aid of a woman who says she has been imprisoned by her father in Saudi Arabia.
Libraries across Wales are celebrating 100 years of Welsh author Roald Dahl at a giant reading scheme.